This inventor holds 0 USPTO granted patents, plus 2 CIPO patents.
Title: Jill Ekstroem: Innovator in Vaccine Development
Introduction
Jill Ekstroem is a prominent inventor based in Sweden, recognized for her contributions to vaccine development. With a focus on innovative compositions and methods, she has made significant strides in the field of immunology. Although she currently holds no patents, her work continues to influence the scientific community.
Latest Patents
Jill's latest patents include a Vaccine Composition Comprising A Fibronectin Binding Protein Or A Fibronectin Binding Peptide. This invention relates to a composition that includes at least one fibronectin binding protein and/or peptide, which is essential for producing a vaccine against microorganisms. Another notable patent is the Quil A Fraction With Low Toxicity And Use Thereof, which explores the use of fraction A of Quil A in combination with other adjuvants to enhance immune response.
Career Highlights
Jill Ekstroem is currently associated with Isconova AB, where she applies her expertise in vaccine research and development. Her work is pivotal in advancing the understanding of immune responses and vaccine efficacy.
Collaborations
Jill collaborates with esteemed colleagues, including Bror Morein and Kefei Hu, to further her research initiatives. These partnerships enhance the scope and impact of her work in the field of immunology.
Conclusion
Jill Ekstroem is a dedicated inventor whose work in vaccine development showcases her commitment to advancing healthcare. Her innovative approaches and collaborations continue to pave the way for future breakthroughs in immunology.